Sonendo (NYSE:SONX) Rating Reiterated by Stifel Nicolaus

Sonendo (NYSE:SONXGet Free Report)‘s stock had its “hold” rating reissued by analysts at Stifel Nicolaus in a report released on Tuesday, MarketBeat reports.

Sonendo Stock Performance

Shares of Sonendo stock traded up $0.01 during trading hours on Tuesday, reaching $0.11. The company had a trading volume of 89,701 shares, compared to its average volume of 376,096. Sonendo has a one year low of $0.05 and a one year high of $2.18. The business has a fifty day simple moving average of $0.17 and a 200 day simple moving average of $0.33. The company has a debt-to-equity ratio of 0.98, a current ratio of 6.83 and a quick ratio of 5.80. The firm has a market cap of $7.16 million, a PE ratio of -0.15 and a beta of 1.77.

Institutional Investors Weigh In On Sonendo

Hedge funds have recently added to or reduced their stakes in the company. Pura Vida Investments LLC lifted its stake in Sonendo by 2.9% during the second quarter. Pura Vida Investments LLC now owns 4,672,145 shares of the company’s stock worth $6,354,000 after purchasing an additional 130,340 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Sonendo by 126.0% in the second quarter. BlackRock Inc. now owns 117,107 shares of the company’s stock worth $159,000 after buying an additional 65,286 shares during the period. Jane Street Group LLC increased its holdings in shares of Sonendo by 1,133.4% in the third quarter. Jane Street Group LLC now owns 138,672 shares of the company’s stock worth $148,000 after buying an additional 127,429 shares during the period. State Street Corp purchased a new position in shares of Sonendo in the first quarter worth about $83,000. Finally, Charles Schwab Investment Management Inc. purchased a new position in shares of Sonendo in the fourth quarter worth about $69,000. Institutional investors own 59.92% of the company’s stock.

About Sonendo

(Get Free Report)

Sonendo, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.

Featured Articles

Receive News & Ratings for Sonendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonendo and related companies with MarketBeat.com's FREE daily email newsletter.